Clinical trials have been performed in children (61 patients aged 2 - 11) and children and adolescents (481 patients aged 9 - 19 years), comparing insulin lispro to human soluble insulin.
Kwenziwa izivivinyo zemitholampilo ezibandakanya izingane (iziguli ezingama-61 ezineminyaka emi-2 kuya kweli-11), kanye nezingane kanye nentsha (iziguli ezingama-481 ezineminyaka engu-9 kuye kwayi-19), eziqhathanisa ne-insulin lispro ne-insulle yabantu i-insulin.Izici ze-pharmacodynamic ze-lyspro insulin ezinganeni ziyafana nezabantu abadala.